In this post, we will breakdown the history of CHG, its introduction into the vascular access space, and Center for Disease Control (CDC) recommendations regarding its use.
In recent years, many clinical studies have been performed to compare outcomes of PIVCs that were changed routinely against those that were only changed when clinically indicated (presence of a complication, infection, device malfunction, etc.). With over 300 million PIVCs sold in the US every year, the economic and clinical outcomes of such a policy change could be vast (2).
This was Lineus Medical’s first year exhibiting at the Society of Interventional Radiology’s Annual Meeting, and we could not have been happier with the conference. Hosted in downtown Los Angeles, California at the Los Angeles Convention Center, we got the chance to meet hundreds of Interventional Radiologists and talk with them about the issues they face in their medical practice. The opportunity to speak one on one with radiologists from all over the world was unique, and the insights that were shared about inserting and securing central venous catheters was valuable.
One of the primary issues we discussed with these physicians was, “Do you find in your practice that your patients pull out, or dislodge, their central lines?” Not surprisingly, the overwhelming majority of the physicians responded that this is a common issue that requires them to take time out of their busy day to install a new line. When central lines are supposed to stay in for weeks or even months, inserting a new one a few days after the original line was installed is both wasteful and time consuming. During our discussions, we were able to demonstrate how the SafeBreak Vascular separates prior to damaging levels of tension on the IV line to help protect the IV catheter from potentially harmful forces, and the physician’s response to the demo was incredible. Because they had never seen a device like this, many of their initial reactions were of surprise and intrigue. Beyond their initial reactions to the product, their analysis of the product was consistently that it would be helpful in preventing the dislodgement of their central venous catheters.
The 2018 Society of Interventional Radiology annual meeting was a huge success for Lineus Medical, and we can’t wait to continue the discussion with physicians to learn more about how the SafeBreak Vascular can help them in their practice. Check out this short video below that recaps our time at the SIR conference in LA!
SafeBreak® Vascular is not yet 510(k) cleared by the United States Food and Drug Administration and is not yet for sale.
MKG-0046 08/18 Rev. 00
There is no doubt that innovative adhesives have spurred advancements in wound care over the years. Intricate border designs and strong adhesive components allow devices to be secured and wounds to be dressed. But as these medical adhesives grew stronger, human skin remained the same, creating a problem for people with poor skin integrity.